News Focus
News Focus
Followers 166
Posts 2897
Boards Moderated 0
Alias Born 01/29/2004

Re: BIOChecker4 post# 493743

Monday, 07/14/2025 9:07:56 PM

Monday, July 14, 2025 9:07:56 PM

Post# of 517743
But What About Anavex 3-71 and Schizophrenia?

Don’t say you weren’t warned.

Ok, we've been "warned" about blarcamesine's failure to treat or prevent Alzheimer's. One would'a thought those 50-some medical professionals who signed in approval of the journal article would have, could have seen and understood all of the negatives. Why didn't they? How could they have missed all of the negatives in the study?

So, you are always right in your copious blarcamesine naysayings. Blarcamesine is never going to be approved, by either the European Medicines Agency or the Food and Drug Administration.

Now, please, if you will, tell us how Anavex 3-71 can't and won't work for schizophrenia. Anavex Life Sciences Corp will be a going, profit-making concern solely on the revenues it receives to treat schizophrenia. Please, help us out. You've "checked" everything. For the record, tell us why that can't or won't happen.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News